Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- congestive heart failure, pneumonia, and malignancy
- dyspnea
- dullness to percussion
Outros fatores diagnósticos
- pleuritic chest pain
- cough
- absent or decreased breath sounds
- decreased or absent tactile fremitus
Fatores de risco
- congestive heart failure
- pneumonia
- malignancy
- pulmonary embolism
- recent coronary artery bypass graft surgery
- recent myocardial infarction
- occupational lung disease
- rheumatoid arthritis
- systemic lupus erythematosus
- renal failure
- drug-induced pleural effusion
- recent ovarian stimulation treatment
- chylothorax
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- posteroanterior and lateral chest x-ray
- pleural ultrasound
- LDH and protein in pleural fluid and serum
- red blood cell count in pleural fluid
- WBC count and differential of pleural fluid
- cytology of pleural fluid
- culture of pleural fluid
- pH of pleural fluid
- glucose in pleural fluid
- protein gradient
- CBC
- CRP
- blood culture
- sputum Gram stain and culture
- N-terminal pro-brain natriuretic peptide (NT-pro-BNP) in pleural fluid
Investigações a serem consideradas
- pleural fluid cholesterol level
- thoracic CT scan
- thoracic MRI
- helical CT scan
- amylase in pleural fluid
- adenosine deaminase (ADA) level in pleural fluid
- lipid analysis of pleural fluid
- antinuclear antibody (ANA) analysis of pleural fluid
- thoracoscopy
- bronchoscopy
- pleural biopsy
- interferon-gamma in pleural fluid and real-time polymerase chain reaction of pleural fluid
- procalcitonin
Novos exames
- tumor markers in pleural fluid
Algoritmo de tratamento
congestive heart failure
infective
malignant: poor performance status or limited lifespan (Karnofsky score ≤30% or ECOG score of ≥2)
malignant: good performance status (Karnofsky score >30% or ECOG score of 0 or 1)
persistent empyema despite chest tube
recurrent symptomatic malignant effusions
recurrent benign effusion
Colaboradores
Autores
Orhan Orhan, MBBS, BSc, FRCP, SFHEA, MSc
Consultant Respiratory Physician
Chelsea and Westminster Hospital NHS Foundation Trust
London
UK
Declarações
OO declares that he has no competing interests.
Agradecimentos
Dr Orhan Orhan would like to gratefully acknowledge Drs Clare Ross, Philip W. Ind, Anob M. Chakrabarti, Richard Light, Amber Degryse, Rachel J. Davies, and Peter M. George, previous contributors to this topic.
Declarações
RL received speaking fees provided by Cardinal Health; owned stock in Denver Biomaterials until it was purchased by Cardinal Health; received fees for consulting from Denver Biomaterials; and is an author of references cited in this topic. CR, PWI, AMC, AD, RJD, and PMG declare that they have no competing interests.
Revisores
Y.C. Gary Lee, MBChB, PhD, FCCP, FRACP
Consultant Chest Physician and Senior Lecturer
Oxford Centre for Respiratory Medicine and University of Oxford Churchill Hospital
Oxford
UK
Declarações
YCGL declares that he has no competing interests.
Clare Hooper, MBBS
Pleural Research Registrar
North Bristol Lung Centre
Southmead Hospital
Westbury on Trym
Bristol
UK
Declarações
CH declares that she has no competing interests.
Steven Sahn, MD
Professor of Medicine and Director
Division of Pulmonary/Critical Care/Allergy/Sleep Medicine
Medical University of South Carolina
Charleston
SC
Declarações
SS declares that he has no competing interests.
Diagnósticos diferenciais
- Pleural thickening
- Pulmonary collapse and consolidation
- Elevated hemidiaphragm
Mais Diagnósticos diferenciaisDiretrizes
- ACR appropriateness criteria: chylothorax treatment planning
- Pleural disease
Mais DiretrizesFolhetos informativos para os pacientes
Pleural effusion
Chest drain insertion
Mais Folhetos informativos para os pacientesVideos
Pleural aspiration animated demonstration
Insertion of intercostal drain, Seldinger technique: animated demonstration
Mais vídeosConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal